Centurion Wealth Management LLC Sells 1,157 Shares of UnitedHealth Group Incorporated $UNH

Centurion Wealth Management LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,868 shares of the healthcare conglomerate’s stock after selling 1,157 shares during the period. Centurion Wealth Management LLC’s holdings in UnitedHealth Group were worth $583,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Wilson & Boucher Capital Management LLC lifted its position in UnitedHealth Group by 7.4% during the second quarter. Wilson & Boucher Capital Management LLC now owns 2,710 shares of the healthcare conglomerate’s stock valued at $845,000 after purchasing an additional 186 shares during the period. RDA Financial Network boosted its stake in shares of UnitedHealth Group by 8.9% during the 2nd quarter. RDA Financial Network now owns 10,108 shares of the healthcare conglomerate’s stock worth $3,153,000 after acquiring an additional 826 shares during the last quarter. TrueWealth Advisors LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $426,000. Garde Capital Inc. boosted its stake in shares of UnitedHealth Group by 10.0% during the 2nd quarter. Garde Capital Inc. now owns 485 shares of the healthcare conglomerate’s stock worth $151,000 after acquiring an additional 44 shares during the last quarter. Finally, Trust Co of the South boosted its stake in shares of UnitedHealth Group by 3.1% during the 2nd quarter. Trust Co of the South now owns 2,489 shares of the healthcare conglomerate’s stock worth $776,000 after acquiring an additional 76 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $352.61 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $319.35 billion, a P/E ratio of 15.28, a P/E/G ratio of 2.31 and a beta of 0.45. The firm’s fifty day moving average is $291.98 and its two-hundred day moving average is $369.01. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Piper Sandler dropped their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. HSBC restated a “reduce” rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Sanford C. Bernstein raised their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.